Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Advancements In Cataract Surgery Eliminates The Need Of Glasses

Cataract surgery used to be a "one-size-fits-all" approach. Today's technological advancements mean that cutting-edge procedures, such as those utilized at the West Boca Eye Center, provide bespoke solutions based on unique eye characteristics that can remove the need for wearing glasses once and for all.


News provided by

West Boca Eye Center

Oct 25, 2019, 13:25 ET

Share this article

Share toX

Share this article

Share toX

West Boca Eye Center
West Boca Eye Center

BOCA RATON, Fla., Oct. 25, 2019 /PRNewswire-PRWeb/ -- Cataracts are an all-too-common condition that develop in everyone as they age. They can also be caused by disease, the use of steroid medications, and injury to the eye. The condition causes gradual deterioration to the lens within the eye, reducing vision dramatically and having a very real impact on the quality of life. Up until recently, while cataract surgery was able to remove such affected lenses, ophthalmologists had only a single choice of monofocal artificial lens to use as a replacement. This meant that many patients still had to rely on the use of corrective lenses after the procedure was carried out.

In recent years, revolutionary advances in technology have brought about several new multifocal, premium intraocular lenses (IOLs). Their recent FDA approval means that eye surgeons can now tailor-make a solution that fits with the individual characteristics of the patient's eye, as well as their personal lifestyle needs.

Use of the AcrySof ReSTOR is one of the leading intraocular lens implant selections used by leading eye surgeon, Brent Bellotte, MD, at the West Boca Eye Center.

Post this

The Custom Cataract Surgery Breakthrough

Historically, the majority of patients who underwent cataract surgery still had to use eye-glasses post-procedure. This was because artificial lenses only corrected issues such as near and farsightedness. Conditions, such as astigmatism or presbyopia, still warranted the use of glasses or contact lenses. Many people also had issues with night vision—such as the appearance of halos or glare—as well as difficulty focusing in situations such as driving, reading, or viewing a computer due to this residual refractive error with standard IOLs.

The development and approval of premium IOLs, such as trifocal, accommodative, multifocal, and toric implants, have proved game-changing. The use of these allows eye doctors to determine the type of lens necessary for the individual, based on personal vision issues, as well as their particular lifestyle needs—in some cases, reducing or even completely eliminating your glasses or contact lenses afterwards.

Groundbreaking Technology, Patented Optic Design

One of the remarkable lens implants utilized in this innovative cataract surgery is the AcrySof ReSTOR. This is a patented design that's been proven in multiple FDA clinical trials to provide the majority of patients with the life-changing advantage of near-perfect vision, without the use of glasses, following the simple surgical procedure.

Use of the AcrySof ReSTOR is one of the leading intraocular lens implant selections used by leading eye surgeon, Brent Bellotte, MD, at the West Boca Eye Center. The unique aspect of the lens is that it utilizes a combination of three complementary techniques, known as apodization, diffraction, and refraction. These provide the eye with the ability to once again focus easily and quickly at various distances—near, far, and immediate—as well as delivering clear vision in all lighting situations.

The Highest Level Of Freedom From Glasses Ever Demonstrated In IOL Clinical Trials

FDA clinical trials show that 80 percent of patients who had the lens implanted experienced total freedom from glasses/contact lenses post-implant, 94 percent could read the paper and drive, and nearly 94 percent would happily have the procedure again.

The patented AcrySof ReSTOR is proven to offer the highest level of freedom from glasses post-procedure of any artificial lens ever brought to market. Combining quality vision with lifestyle enhancement means that patients have more choices than ever at finding an optical solution that's completely tailored to their individual needs.

The suitability of such multifocal IOLs is something individuals need to consider with the professional advice of their eye doctor. Dr. Brent Bellotte and the team at the West Boca Eye Center are pioneers of such surgery, working with each person to determine their ultimate bespoke solution. Patients at the clinic benefit from the very latest advancements in vision solutions, with Brent Bellotte MD being an industry leader in the specialty of cataract surgery and has been voted the nation's top ophthalmologist.

For more information and to discover more about how such premium IOLs can provide crystal clear vision and a life free from glasses, visit https://westbocaeyecenter.com/.

SOURCE West Boca Eye Center

Related Links

https://westbocaeyecenter.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.